Incidence, risk factors, and clinical outcomes associated with Epstein‐Barr virus‐DNAemia and Epstein‐Barr virus‐associated disease in patients after haploidentical allogeneic stem cell transplantation: A single‐center study
- 13 March 2020
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 34 (6) , e13856
Abstract
Human leukocyte antigen (HLA)‐haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) is an effective alternative to HLA‐matched transplantation. However, Epstein‐Barr virus (EBV) infection causes morbidity and mortality in patients undergoing haplo‐HSCT. Here, we retrospectively evaluated the incidence and risk factors of EBV‐DNAemia and EBV‐associated diseases in 131 patients who underwent haplo‐HSCT. Patients were classified into the no EBV infection groups, EBV‐DNAemia group and EBV‐associated disease group. Cumulative incidences of acute graft‐vs‐host disease, EBV infections, overall survival (OS), and relapse were analyzed. The cumulative incidences of EBV‐DNAemia and EBV‐associated disease were 26.9% and 33.3%, respectively. In multivariate analysis, cytomegalovirus (CMV)‐DNAemia was confirmed as an independent risk factor associated with EBV‐DNAemia and EBV‐associated disease. Patients with EBV‐associated disease had higher transplant‐related mortality (TRM) rates and lower OS rates, but similar relapse rates. Overall, these findings demonstrated the cumulative incidences of EBV‐DNAemia and EBV‐associated disease and identified correlations of EBV infection with TRM, relapse, and OS. Additionally, CMV‐DNAemia was a risk factor for EBV‐DNAemia and EBV‐associated disease.Keywords
This publication has 18 references indexed in Scilit:
- Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical OutcomesTransplantation and Cellular Therapy, 2015
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related DonorsTransplantation and Cellular Therapy, 2014
- Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling GraftsTransplantation and Cellular Therapy, 2014
- Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2014
- ControlledEpstein–Barr virus reactivation after allogeneic transplantation is associated with improved survivalEuropean Journal of Haematology, 2014
- Epstein–Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivationClinical Transplantation, 2013
- Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationClinical Infectious Diseases, 2013
- Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignanciesBone Marrow Transplantation, 2006
- Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantationBlood, 2006
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974